Outcomes of pulmonary arterial hypertension therapy in Australia: is monotherapy adequate?


BACKGROUND In Australia, government-subsidised treatment of pulmonary arterial hypertension (PAH) is limited to monotherapy. Recent international guidelines advocate that initial combination therapy be considered for all symptomatic PAH patients. AIM To characterise 'real-life' outcomes in PAH patients initiated on monotherapy. METHODS We performed a… (More)
DOI: 10.1111/imj.13495


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics